Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ContraFectOvid TherapeuticsTyme TechnologiesVerastemAvenue Therapeutics
SymbolNASDAQ:CFRXNASDAQ:OVIDNASDAQ:TYMENASDAQ:VSTMNASDAQ:ATXI
Price Information
Current Price$5.50$2.83$1.28$2.93$8.29
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$18.50$14.00$9.50$5.95$12.00
% Upside from Price Target236.36% upside394.70% upside642.19% upside103.07% upside44.75% upside
Trade Information
Market Cap$82.03 million$152.64 million$149.87 million$421.83 million$148.31 million
Beta1.022.080.551.860.08
Average Volume228,688577,926509,3342,709,27164,235
Sales & Book Value
Annual RevenueN/AN/AN/A$17.46 millionN/A
Price / SalesN/AN/AN/A26.62N/A
Cashflow$0.65 per shareN/AN/AN/AN/A
Price / Cash8.51N/AN/AN/AN/A
Book Value$1.01 per share$1.46 per share$0.09 per share$0.09 per share$0.41 per share
Price / BookN/AN/AN/A32.56N/A
Profitability
Net Income$-12,790,000.00$-60,460,000.00$-32,980,000.00$-149,210,000.00$-25,910,000.00
EPS$1.11($1.54)($0.32)($2.00)($1.65)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-854.77%N/A
Return on Equity (ROE)60.90%-119.28%-341.27%-339.98%-195.47%
Return on Assets (ROA)27.37%-99.48%-150.85%-70.78%-151.88%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.21%N/AN/A14.93%N/A
Current Ratio3.06%7.58%2.32%2.84%4.22%
Quick Ratio3.06%7.58%2.32%2.74%4.22%
Ownership Information
Institutional Ownership PercentageN/A32.48%11.76%21.23%9.43%
Insider Ownership Percentage3.70%29.80%27.17%6.10%5.00%
Miscellaneous
Employees2055111696
Shares Outstanding15.33 million54.71 million122.84 million158.61 million16.68 million
Next Earnings Date5/8/2020 (Estimated)5/5/2020 (Estimated)6/10/2020 (Estimated)5/14/2020 (Estimated)5/11/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel